Orientin alleviates cognitive deficits and oxidative stress in Aβ1–42-induced mouse model of Alzheimer's disease
- 1 January 2015
- journal article
- Published by Elsevier in Life Sciences
- Vol. 121, 104-109
- https://doi.org/10.1016/j.lfs.2014.11.021
Abstract
No abstract availableKeywords
Funding Information
- National Nature Science Foundation of China (81200839, 81230026, 81171085)
- Natural Science Foundation (BL2012013)
- Bureau of Health (LJ201101)
This publication has 36 references indexed in Scilit:
- Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced Neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In VivoCNS Neuroscience & Therapeutics, 2012
- Amelioration of Alzheimer’s disease by neuroprotective effect of sulforaphane in animal modelAmyloid, 2012
- Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairmentFree Radical Biology & Medicine, 2012
- Diammonium Glycyrrhizinate Upregulates PGC-1α and Protects against Aβ1–42-Induced NeurotoxicityPLOS ONE, 2012
- Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid PeroxidationPLOS ONE, 2011
- Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cellsNeurochemistry International, 2010
- Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataractMechanisms of Ageing and Development, 2010
- Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's DiseaseJournal of Neuroscience, 2009
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology and Experimental Neurology, 2007